HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  


Search:



The Web

Rediff








Business
Portfolio Tracker
Business News
Specials
Columns
Market Report
Mutual Funds
Interviews
Tutorials
Message Board
Stock Talk
Press Releases



Home > Business > Business Headline > Report

Govt to review bulk drugs import norm

BS Economy Bureau in New Delhi | May 16, 2003 13:31 IST

The government has decided to review the decision of mandatory registration for bulk drug importers.

Officials of the commerce and health ministries would meet on May 20 to consider the pharmaceutical industry's demand, director-general of foreign trade Labanyendu Mansingh said at an open house with exporters organised by Chemexcil in New Delhi on Thursday.

Exporters are demanding that registration of suppliers should not be mandatory for products, which are to be further exported, because it increased costs and affected competitiveness of products.

The government had introduced the registration norms from April this year, based on practices in the US, and warned that country should be ready to face high prices from registered suppliers.

"The government's decision is impractical, especially for people who are exporting bulk drugs after processing some imported drugs," said BK Bhuwania, president and chief executive officer of Coral Drugs Pvt Ltd, an exporter of bulk formulations for cancer drugs.

Representatives of the Indian Drug Manufacturers' Association had also met DGFT officials earlier this week to press for the removal of registration requirements.

Bulk drug suppliers have to register themselves for their product for import and use in India, according to a government notification.

Stating that some suppliers were merely traders and not manufacturers and it was difficult for them to get registered, exporters suggested that the government could control movement of imports for exports bringing advance licences.

Exporters also said traders, who were supplying small quantities would not be keen on registration and they would be either forced to stop exports of particular products or switch to those registered and charging premium, reducing the competitiveness of their products.


Powered by



Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor



Related Stories


Nicholas Piramal stages recovery

Shasun Chemicals catalysed

Alembic rises on value buying



People Who Read This Also Read


ITC Hotels gets good reception

SARS may hit Infosys' China plan

Cell industry may see 39% CAGR







HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  
© 2003 rediff.com India Limited. All Rights Reserved.